Please select the option that best describes you:
Topics:
Radiation Oncology • Gastrointestinal Cancers • Medical Oncology • Colorectal Cancer • Radiology
How was treatment response assessed on the PROSPECT trial?
Specifically, on re-staging imaging, would the tumor regression be strictly defined by reduction in cranio-caudal direction only, or would other measurements need to be taken into consideration?
Answer from: Radiation Oncologist at Academic Institution
Dr. Harvey reached out to his colleague, Dr. Marc Gollub, director of radiology at Memorial Sloan Kettering with expertise in gastrointestinal imaging (and who was the radiologist who collaborated on PROSPECT), for his thoughts on this question. Here is his answer:
I had to “create&...
Sign in or Register to read more